Belzutifan 40mg tablets
- SNOMED code
41140911000001102- Active compound
- Belzutifan
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Belzutifan
— 40 mg
based on ingredient substance
- Form & Route
- tablet.oral
Oral tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Welireg 40mg tablets (Merck Sharp & Dohme (UK) Ltd)
Welireg 40mg tablets
- SNOMED code
41117111000001109- Supplier
- Merck Sharp & Dohme (UK) Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Welireg 40mg tablets (Merck Sharp & Dohme (UK) Ltd) 90 tablet41117211000001103 ref. pack | 💯 Available Legal category: POM | 001917780238170191778023817End: | NHS Indicative Price £11,936 | • Hospital |
| — |
Reference packs
Belzutifan 40mg tablets 90 tablet
- SNOMED code
41117011000001108- Quantity and unit
- 90 tablet
- Packs